Webinar: From Utah the U.K.—Why Companies Should Consider an IPO on the London Stock Exchange
May 14, 2021
On May 12, 2021, BioUtah presented a webinar featuring representatives of the banking firm, Stifel, as well as James McCullough, CEO of Renalytix, a Utah based company. The webinar presented the opportunity for Utah companies to raise capital through an offering on London Stock Exchange’s AIM platform. Renalytix is one of the most successful companies in years to do just that skipping the traditional process of raising early stage and venture capital.
If you did not have the opportunity to tune in, you can click on the link below to watch the full one hour webinar. It is a unique opportunity for raising capital.
Recent News
- Merit Medical Acquires Biolife Delaware
- Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
- BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies
- KyphoLift Debuts at ISMRM 2025: Transforming Patient Positioning for Safer, More Accurate Imaging
- Kelvyn Cullimore: An Unfair Penalty on Life-Saving Pills
- Merit Medical Announces Health Canada Approval of the WRAPSODY® Cell-Impermeable Endoprosthesis
